| 2024 |
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low Molecular Weight Heparin - The OSCAR-UK Study
10.1055/a-2259-0662
Authors: A. Cohen, C. Wallenhorst, M. Rivera, C. Ay, B. Schaefer, K. Abdelgawwad, G. Psaroudakis, G. Brobert, A. Ekbom, A. Y. Y. Lee, A. Khorana, C. Becattini, M. Carrier, C. Coleman, C. Martinez |
| 2024 |
Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011-2021
10.1007/s00415-023-12165-4
Authors: R. Shankar, X. Marston, V. Danielson, Do Rego, R. Lasagne, O. Williams, L. Groves |
| 2024 |
Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: A cohort study of primary care data
10.1016/j.diabres.2024.111641
Authors: I. Carey, J. Critchley, A. U, D. Cook, S. DeWilde, E. Limb, L. Bowen, S. Woolford, P. Whincup, N. Sattar, A. Panahloo, T. Harris |
| 2024 |
Burden of Disease and Treatment Patterns Amongst Patients With Vitiligo: Findings From a National, Longitudinal Retrospective Study in the United Kingdom
10.1093/bjd/ljae133
Authors: V. Eleftheriadou, C. Delattre, S. Chetty-Mhlanga, C. Lee, L. Girardat-Rotar, I. Khan, A. Mathew, A. Thompson |
| 2024 |
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
10.1136/rmdopen-2023-003980
Authors: A. Abhishek, M. Grainge, T. Card, H. Williams, M. Taal, G. Aithal, C. Fox, C. Mallen, M. Stevenson, G. Nakafero, R. Riley |
| 2024 |
Persons diagnosed with COVID-19 in England in the Clinical Practice Research Datalink (CPRD): a cohort description
10.1136/bmjopen-2023-073866
Authors: K. Andersen, L. McGrath, M. Reimbaeva, D. Mendes, J. Nguyen, K. Rai, T. Tritton, C. Tsang, D. Malhotra, J. Yang |
| 2024 |
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study
10.1136/bmjopen-2023-078135
Authors: R. Hopkins, K. Young, N. Thomas, J. Godwin, D. Raja, B. Mateen, R. Challen, S. Vollmer, B. Shields, A. McGovern, J. Dennis |
| 2024 |
Identification of misclassified pregnancy episodes in women of childbearing potential exposed to drugs with known teratogenic potential in the CPRD GOLD Pregnancy Register
10.1002/pds.5761
Authors: C. Lee, S. Rizzi, A. Bierrenbach, L. Antunes, N. Nissinen, O. Rocha, J. Campbell, C. Minassian, S. Hodgson, A. Broe |
| 2024 |
Use of drugs for hyperlipidaemia and diabetes and risk of primary and secondary brain tumours: nested case-control studies using the UK Clinical Practice Research Datalink (CPRD)
10.1136/bmjopen-2023-072026
Authors: J. Robinson, R. Martin, M. Ozawa, M. Elwenspoek, M. Redaniel, K. Kurian, Y. Ben-Shlomo |
| 2024 |
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
10.1016/s2213-2600(23)00414-9
Authors: M. Català, N. Mercadé-Besora, R. Kolde, N. Trinh, E. Roel, E. Burn, T. Rathod-Mistry, K. Kostka, W . Y. Man, A. Delmestri, H. Nordeng, A. Uusküla, T. Duarte-Salles, D. Prieto-Alhambra, A. Jödicke |
| 2024 |
Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998-2019): A population-based assessment
10.1002/pds.5752
Authors: R. Masarwa, P. Reynier, C. Lefebvre, R. Platt, J. Delaney, K. Filion |
| 2024 |
Adverse respiratory outcomes amongst patients with resolved asthma: matched retrospective cohort study
10.3399/bjgp.2023.0271
Authors: H. Jones, B. Cumins, R. Cannings-John, H. Ahmed |
| 2024 |
Population-based study of alcohol-related liver disease in England 2001-2018: Influence of socioeconomic position
10.14309/ajg.0000000000002677
Authors: G. Askgaard, P. Jepsen, M. Jensen, A. Kann, J. Morling, F. Kraglund, T. Card, C. Crooks, J. West |
| 2024 |
Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study
10.1161/strokeaha.123.045098
Authors: R. Chiv, S. Beradid, S. Suissa, C. Renoux |
| 2024 |
Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucoma
10.1080/03007995.2024.2322048
Authors: M. Cordeiro, P. Denis, C. Astarita, J. Belsey, M. Rivas, J. García-Feijoo |
| 2024 |
Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort Study
10.1097/inf.0000000000004213
Authors: J. Yang, K. Andersen, K. Rai, T. Tritton, T. Mugwagwa, C. Tsang, M. Reimbaeva, L. McGrath, P. Payne, B. Backhouse, D. Mendes, R. Butfield, R. Wood, J. Nguyen |
| 2024 |
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
10.1016/s2213-2600(23)00414-9
Authors: M. Català, N. Mercadé-Besora, R. Kolde, N. Trinh, E. Roel, E. Burn, T. Rathod-Mistry, K. Kostka, W . Y. Man, A. Delmestri, H. Nordeng, A. Uusküla, T. Duarte-Salles, D. Prieto-Alhambra, A. Jödicke |
| 2024 |
Identifying prior signals of bipolar disorder using primary care electronic health records: a nested case-control study
10.3399/bjgp.2022.0286
Authors: C. Morgan, D. Ashcroft, C. Chew-Graham, M. Sperrin, R. Webb, A. Francis, J. Scott, A. Yung |
| 2024 |
Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data
10.1186/s12931-024-02672-x
Authors: H. Whittaker, A. Torkpour, J. Quint |
| 2024 |
Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: The RECUR England study
10.1016/j.ijid.2024.02.010
Authors: S. Ghosh, A. Antunes, H. Rinta-Kokko, E. Chaparova, S. Lay-Flurrie, A. Tricotel, F. Andersson |
| 2024 |
Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK
10.1007/s10072-024-07336-8
Authors: A. Abbasi, H. Fryk, J. Rudnik, R. White, M. Vanderkelen, A. Scowcroft, K. Bonar |
| 2024 |
Ethnic differences in depression and anxiety among adults with atopic eczema: Population-based matched cohort studies within UK primary care
10.1002/clt2.12348
Authors: E. Adesanya, A. Henderson, J. Hayes, A. Lewin, R. Mathur, A. Mulick, C. Morton, C. Smith, S. Langan, K. Mansfield |
| 2024 |
Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study
10.1016/j.ijid.2024.01.002
Authors: S. Ghosh, A. Antunes, H. Rinta-Kokko, E. Chaparova, S. Lay-Flurrie, A. Tricotel, F. Andersson |
| 2024 |
Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding
10.1001/jamanetworkopen.2024.3208
Authors: A. Rahman, R. Platt, S. Beradid, J. Boivin, S. Rej, C. Renoux |
| 2024 |
Uptake and safety of pneumococcal vaccination in adults with immune mediated inflammatory diseases: a UK wide observational study
10.1093/rheumatology/keae160
Authors: G. Nakafero, M. Grainge, T. Card, C. Mallen, J. Van-Tam, A. Abhishek |
| 2024 |
Risk of fibromyalgia following antibiotic prescriptions: A population-based case-control study
10.1002/ejp.2239
Authors: D. Armstrong, A. Dregan, M. Ashworth, P. White |
| 2024 |
Risk of fractures in half a million survivors of 20 cancers: a population-based matched cohort study using linked English electronic health records
10.1016/s2666-7568(23)00285-4
Authors: E. Buzasi, H. Carreira, G. Funston, K. Mansfield, H. Forbes, H. Strongman, K. Bhaskaran |
| 2024 |
The risk of acute infections in new users of antidepressants: An observational cohort study
10.1016/j.jad.2024.03.002
Authors: N. Aebi, C. Meier, S. Jick, U. Lang, J. Spoendlin |
| 2024 |
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study
10.1136/bmjopen-2023-072361
Authors: A. Czira, V. Banks, G. Requena, R. Wood, T. Tritton, R. Wild, C. Compton, A. Ismaila |
| 2024 |
Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010-2020
10.1136/openhrt-2023-002515
Authors: J. Liaw, D. Liaw, C. Dave |
| 2024 |
Impact of pregnancy vaccine uptake and socio-demographic determinants on subsequent childhood Measles, Mumps and Rubella vaccine uptake: A UK birth cohort study
10.1016/j.vaccine.2023.11.063
Authors: H. Skirrow, K. Foley, H. Bedford, C. Lewis, E. Whittaker, C. Costelloe, S. Saxena |
| 2024 |
The risk of acute infection in association with first ever diagnosed depression: a cohort study
10.1007/s00127-024-02784-1
Authors: N. Aebi, C. Meier, S. Jick, U. Lang, J. Spoendlin |
| 2024 |
Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records
10.1136/bmjdrc-2023-003548
Authors: W. Doran, L. Tunnicliffe, R. Muzambi, C. Rentsch, K. Bhaskaran, L. Smeeth, C. Brayne, D. Williams, N. Chaturvedi, S. Eastwood, S. Dunachie, R. Mathur, C. Warren-Gash |
| 2024 |
Standardizing to Specific Target Populations in Distributed Networks and Multi-Site Pharmacoepidemiologic Studies
10.1093/aje/kwae015
Authors: M. Webster-Clark, K. Filion, R. Platt |
| 2024 |
Familial hypercholesterolaemia in UK primary care: a Clinical Practice Research Datalink study of an under-recognised condition
10.3399/bjgp.2023.0010
Authors: A. Durand, C. Morgan, S. Tinsley, E. Hughes, T. McCormack, C. Bitchell, R. Lahoz |
| 2024 |
Smoking is a Risk Factor for Autoimmune Hepatitis: An English Registry-Based Case-Control Study
10.2147/clep.s439219
Authors: L. Grønbæk, H. Omeife, L. Ban, C. Crooks, T. Card, P. Jepsen, J. West |
| 2024 |
Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study
10.1016/j.canep.2024.102552
Authors: C. Cardwell, R. McDowell, C. Hughes, J. Busby, P. Murchie |
| 2024 |
Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls
10.1016/s2665-9913(23)00338-7
Authors: L. Ferguson, G. Molenberghs, G. Verbeke, K. Rahimi, S. Rao, I. McInnes, J. McMurray, N. Sattar, N. Conrad |
| 2024 |
Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
10.1093/ehjcvp/pvae022
Authors: T. Eroglu, R. Coronel, P. Souverein |
| 2024 |
Predicting incident heart failure from population-based nationwide electronic health records: protocol for a model development and validation study
10.1136/bmjopen-2023-073455
Authors: Y. Nakao, R. Nadarajah, F. Shuweihdi, K. Nakao, A. Fuat, J. Moore, C. Bates, J. Wu, C. Gale |
| 2024 |
The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis
10.3310/kltr7714
Authors: B. Guthrie, G. Rogers, S. Livingstone, D. Morales, P. Donnan, S. Davis, J. Youn, R. Hainsworth, A. Thompson, K. Payne |
| 2024 |
Preventive treatment patterns in the adult migraine population: an observational UK study over 7 years
10.1186/s12875-023-02242-y
Authors: D. Kernick, N. Kondori, A. Pain, J. Mount, C. Appel, M. Ranopa, T. Gulati |
| 2024 |
NSAID prescribing and adverse outcomes in common infections: a population-based cohort study
10.1136/bmjopen-2023-077365
Authors: B. Stuart, R. Venekamp, H. Hounkpatin, S. Wilding, M. Moore, P. Little, M. Gulliford |
| 2024 |
Perceptions on artificial intelligence-based decision-making for coexisting multiple long-term health conditions: protocol for a qualitative study with patients and healthcare professionals
10.1136/bmjopen-2023-077156
Authors: N. Gunathilaka, T. Gooden, J. Cooper, S. Flanagan, T. Marshall, S. Haroon, A. D'Elia, F. Crowe, T. Jackson, K. Nirantharakumar, S. Greenfield |
| 2024 |
Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors
10.1016/j.jad.2024.01.163
Authors: J. Engler, C. Filliter, F. Montastruc, H. Abenhaim, S. Rej, C. Renoux |
| 2024 |
Effect of timeframes to define long term conditions and sociodemographic factors on prevalence of multimorbidity using disease code frequency in primary care electronic health records: retrospective study
10.1136/bmjmed-2022-000474
Authors: T. Beaney, J. Clarke, T. Woodcock, A. Majeed, M. Barahona, P. Aylin |
| 2024 |
Pooling of primary care electronic health record (EHR) data on Huntington's disease (HD) and cancer: establishing comparability of two large UK databases
10.1136/bmjopen-2022-070258
Authors: D. Dedman, R. Williams, K. Bhaskaran, I. Douglas |
| 2024 |
Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study
10.1136/thorax-2023-220259
Authors: A. Wilkinson, E. Maslova, C. Janson, V. Radhakrishnan, J. Quint, N. Budgen, T. Tran, Y. Xu, A. Menzies-Gow, J. Bell |
| 2024 |
Post-hospitalisation asthma management in primary care: a retrospective cohort study
10.3399/bjgp.2023.0214
Authors: D. Punyadasa, N. Simms-Williams, N. Adderley, R. Thayakaran, A. Mansur, K. Nirantharakumar, P. Nagakumar, S. Haroon |
| 2024 |
Prodromal symptoms of rheumatoid arthritis in a primary care database: variation by ethnicity and socioeconomic status
10.1093/rheumatology/keae157
Authors: A. D'Elia, A. Baranskaya, S. Haroon, B. Hammond, N. Adderley, K. Nirantharakumar, J. Chandan, M. Falahee, K. Raza |
